Checkpoint Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Checkpoint Therapeutics

05/08/2021 23:37

* Checkpoint Therapeutics Inc  CKPT.OQ  reported a quarterly
adjusted loss of 12 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 10 cents per share.
* Revenue rose 269% to $155.00 thousand from a year ago; 
analysts expected $114.00 thousand. 
* Checkpoint Therapeutics Inc's reported EPS for the quarter was
a loss of 12 cents​.
* The mean earnings estimate of analysts had risen by
about 15.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Checkpoint Therapeutics Inc shares had fallen by 15.3% this
quarter and lost 5.7% so far this year.
* The company reported a quarterly loss of $9.14 million.
* Wall Street's median 12-month price target for Checkpoint
Therapeutics Inc is $17.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 10:37 p.m.  ​All
figures in US dollars unless otherwise stated